Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 68462-409

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 68462-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lbl225mg60

Lbl225mg60
FDA Label Image

Lbl32560

Lbl32560
FDA Label Image

Lbl425mg60

Lbl425mg60
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a clinical trial analysis comparing the efficacy of Propafenone SR to Placebo. Patients were administered different doses of Propafenone S R (325, 225, and 425 mg bi) and monitored over a period of 300 days. The analysis includes data on the number of patients, Kaplan-Meier curves, and p-values assessing the statistical significance of differences between Propafenone SR and Placebo groups. On day 291, one patient on 325 mg Propafenone had an event leading to a decline in the Kaplan-Meier curve.*
FDA Label Image
Logo
This text only contains one word which appears to be a company name "glenmark". It is not enough to generate a useful description.*
FDA Label Image

Logo2

Logo2
This appears to be a pharmaceutical company called "Glenmark".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.